Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

13.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.2K
Blood Transfusion01:15

Blood Transfusion

3.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Blood Typing01:10

Blood Typing

6.2K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
6.2K
The ABO Blood Group01:12

The ABO Blood Group

9.0K
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
9.0K
Rh Blood Group01:19

Rh Blood Group

4.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.4K
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

216
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving transfusion access through improved policy: a call for a less fragmented blood supply.

Expert review of hematology·2025
Same author

IL-7-mediated expansion of autologous lymphocytes increases CD8<sup>+</sup> VLA-4 expression and accumulation in glioblastoma models.

bioRxiv : the preprint server for biology·2025
Same author

Improving lung cancer tumor-infiltrating lymphocyte (TIL) manufacturing.

Cytotherapy·2025
Same author

IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models.

The Journal of clinical investigation·2025
Same author

A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion.

bioRxiv : the preprint server for biology·2025
Same author

Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing.

Lung cancer (Amsterdam, Netherlands)·2024
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

18.9K

Massive transfusion: blood component ratios.

Devika S Lal1, Beth H Shaz

  • 1New York Blood Center, New York, New York, USA.

Current Opinion in Hematology
|October 10, 2013
PubMed
Summary
This summary is machine-generated.

Fixed ratios in massive transfusion protocols improve survival for trauma patients. Research continues to optimize these ratios and integrate other therapies for better outcomes.

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.4K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

2.1K

Related Experiment Videos

Last Updated: May 7, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

18.9K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.4K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

2.1K

Area of Science:

  • Trauma resuscitation
  • Blood transfusion management
  • Hemorrhagic shock management

Background:

  • Massively transfused trauma patients require optimized resuscitation strategies.
  • Traditional laboratory-based protocols are being replaced by massive transfusion protocols (MTPs).

Purpose of the Study:

  • To review recent advancements in transfusion management for massively transfused trauma patients.
  • To focus on the application of fixed blood component ratios within MTPs.

Main Methods:

  • Review of current literature and clinical practices regarding MTPs.
  • Analysis of studies investigating fixed component ratios (e.g., 1:1:1 RBC:plasma:platelet).

Main Results:

  • Most trauma centers now utilize MTPs with fixed ratios, showing improved survival in severely injured patients.
  • While the 1:1:1 ratio is common, alternative ratios have also shown survival benefits, indicating no single optimal ratio.
  • Antifibrinolytics and point-of-care testing (e.g., thromboelastography) are increasingly integrated into MTPs to manage bleeding, but their optimal use requires further study.

Conclusions:

  • MTPs employing fixed ratios of red blood cells, plasma, and platelets have enhanced survival rates in both civilian and military trauma settings.
  • Ongoing research aims to refine component ratios and integrate adjunctive therapies and testing to further improve patient outcomes.